Your browser doesn't support javascript.
loading
Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland.
Rzymski, Piotr; Pazgan-Simon, Monika; Kamerys, Juliusz; Moniuszko-Malinowska, Anna; Sikorska, Katarzyna; Wernik, Joanna; Zarebska-Michaluk, Dorota; Supronowicz, Lukasz; Sobala-Szczygiel, Barbara; Skrzat-Klapaczynska, Agata; Simon, Krzysztof; Piekarska, Anna; Czupryna, Piotr; Pawlowska, Malgorzata; Brzdek, Michal; Jaroszewicz, Jerzy; Kowalska, Justyna; Renke, Marcin; Flisiak, Robert.
Afiliação
  • Rzymski P; Department of Environmental Medicine, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
  • Pazgan-Simon M; Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), 60-806 Poznan, Poland.
  • Kamerys J; 1st Infectious Diseases Ward, Gromkowski Regional Specialist Hospital, 50-149 Wroclaw, Poland.
  • Moniuszko-Malinowska A; Department of Infectious Diseases and Hepatology, Wroclaw Medical University, 51-149 Wroclaw, Poland.
  • Sikorska K; Department of Infectious Diseases and Hepatology, Medical University of Lódz, 90-549 Lódz, Poland.
  • Wernik J; Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, 15-089 Bialystok, Poland.
  • Zarebska-Michaluk D; Department of Tropical Medicine and Epidemiology, Medical University of Gdansk, 80-210 Gdansk, Poland.
  • Supronowicz L; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 87-100 Torun, Poland.
  • Sobala-Szczygiel B; Department of Infectious Diseases, Jan Kochanowski University, 25-369 Kielce, Poland.
  • Skrzat-Klapaczynska A; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-089 Bialystok, Poland.
  • Simon K; Department of Infectious Diseases and Hepatology, Medical University of Silesia, 40-055 Katowice, Poland.
  • Piekarska A; Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Czupryna P; Department of Infectious Diseases and Hepatology, Wroclaw Medical University, 51-149 Wroclaw, Poland.
  • Pawlowska M; Department of Infectious Diseases and Hepatology, Medical University of Lódz, 90-549 Lódz, Poland.
  • Brzdek M; Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, 15-089 Bialystok, Poland.
  • Jaroszewicz J; Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 87-100 Torun, Poland.
  • Kowalska J; Department of Infectious Diseases, Jan Kochanowski University, 25-369 Kielce, Poland.
  • Renke M; Department of Infectious Diseases and Hepatology, Medical University of Silesia, 40-055 Katowice, Poland.
  • Flisiak R; Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.
Vaccines (Basel) ; 10(4)2022 Apr 04.
Article em En | MEDLINE | ID: mdl-35455306

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article